Terms: = Bone cancer AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1
64260 results:
1. A giant peripheral ossifying fibroma of the maxilla with extreme difficulty in clinical differentiation from malignancy: a case report and review of the literature.
Takagi R; Mori K; Koike T; Tsuyuguchi S; Kanai K; Watanabe Y; Okano M; Noguchi Y; Tanaka A; Kurihara K; Sato K; Ishizaki K; Hayashi Y; Imanishi Y
J Med Case Rep; 2024 May; 18(1):220. PubMed ID: 38702820
[TBL] [Abstract] [Full Text] [Related]
2. Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.
Han X; Jiang X; He J; Zheng G; Xiong Y; Wen Y; Yang Y; He D; Chen Q; Zhao Y; Li Y; Wu W; Cai Z
Cancer Med; 2024 May; 13(9):e7232. PubMed ID: 38698679
[TBL] [Abstract] [Full Text] [Related]
3. Three-dimensional printed custom-made modular talus prosthesis in patients with talus malignant tumor resection.
He X; Lu M; Zou C; Li Z; Gong T; Kenmegne GR; Wang Y; Luo Y; Zhou Y; Min L; Tu C
J Orthop Surg Res; 2024 May; 19(1):273. PubMed ID: 38698477
[TBL] [Abstract] [Full Text] [Related]
4. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
Klabusay M; Bábková B
Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
[TBL] [Abstract] [Full Text] [Related]
5. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Marvaso G; Jereczek-Fossa BA; Zaffaroni M; Vincini MG; Corrao G; Andratschke N; Balagamwala EH; Bedke J; Blanck O; Capitanio U; Correa RJM; De Meerleer G; Franzese C; Gaeta A; Gandini S; Garibaldi C; Gerszten PC; Gillessen S; Grubb WR; Guckenberger M; Hannan R; Jhaveri PM; Josipovic M; Kerkmeijer LGW; Lehrer EJ; Lindskog M; Louie AV; Nguyen QN; Ost P; Palma DA; Procopio G; Rossi M; Staehler M; Tree AC; Tsang YM; Van As N; Zaorsky NG; Zilli T; Pasquier D; Siva S
Lancet Oncol; 2024 May; 25(5):e193-e204. PubMed ID: 38697165
[TBL] [Abstract] [Full Text] [Related]
6. Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy.
Yan J; Bhadane R; Ran M; Ma X; Li Y; Zheng D; Salo-Ahen OMH; Zhang H
Nat Commun; 2024 May; 15(1):3684. PubMed ID: 38693181
[TBL] [Abstract] [Full Text] [Related]
7. Structure-sparing resection for the management of cervical chordomas: a retrospective institutional series.
Levy AS; Jamshidi AM; Costello MC; Levi AD
Neurosurg Focus; 2024 May; 56(5):E6. PubMed ID: 38691869
[TBL] [Abstract] [Full Text] [Related]
8. Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
Ghaith AK; Nguyen R; El-Hajj VG; Montaser A; De Biase G; Ravindran K; Perez-Vega C; Lee SJ; Dominari A; Battistin U; Suárez-Meade P; Moussalem C; Patel NP; Kalani MA; Clarke MJ; Rose PS; Bydon M; Abode-Iyamah K; Akinduro OO
Neurosurg Focus; 2024 May; 56(5):E9. PubMed ID: 38691864
[TBL] [Abstract] [Full Text] [Related]
9. Multidisciplinary surgical considerations for en bloc resection of sacral chordoma: review of recent advances and a contemporary single-center series.
Schroeder C; de Lomba WC; Leary OP; De la Garza Ramos R; Gillette JS; Miner TJ; Woo AS; Fridley JS; Gokaslan ZL; Zadnik Sullivan PL
Neurosurg Focus; 2024 May; 56(5):E7. PubMed ID: 38691863
[TBL] [Abstract] [Full Text] [Related]
10. Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
Palavani LB; Borges P; Andreão FF; Borges J; Batista S; Oliveira LB; Ferreira MY; Reis PCA; Pontes J; Negri H; Beer-Furlan A; Krishna C; Bertani R; Rassi MS
Neurosurg Focus; 2024 May; 56(5):E11. PubMed ID: 38691862
[TBL] [Abstract] [Full Text] [Related]
11. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
[TBL] [Abstract] [Full Text] [Related]
12. Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.
Rychen J; Constanzo F; Xu Y; Johnstone TM; Bex A; Rinaldi M; Lee CK; Fernandez-Miranda JC
Neurosurg Focus; 2024 May; 56(5):E3. PubMed ID: 38691859
[TBL] [Abstract] [Full Text] [Related]
13. The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma.
Hoppe M; Gersey ZC; Muthiah N; Abdallah HM; Plute T; Abou-Al-Shaar H; Wang EW; Snyderman CH; Zenonos GA; Gardner PA
Neurosurg Focus; 2024 May; 56(5):E16. PubMed ID: 38691858
[TBL] [Abstract] [Full Text] [Related]
14. A comparison of endoscopic endonasal versus open approaches for skull base chordoma: a comprehensive National cancer Database analysis.
Soffer JM; Ulloa R; Chen S; Ziltzer RS; Patel VA; Polster SP
Neurosurg Focus; 2024 May; 56(5):E5. PubMed ID: 38691856
[TBL] [Abstract] [Full Text] [Related]
15. The burden of skull base chordomas: insights from a meta-analysis of observational studies.
Fiore G; Porto E; Bertani GA; Marcus HJ; Saladino A; Pradilla G; DiMeco F; Locatelli M
Neurosurg Focus; 2024 May; 56(5):E13. PubMed ID: 38691853
[TBL] [Abstract] [Full Text] [Related]
16. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
[TBL] [Abstract] [Full Text] [Related]
17. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
[TBL] [Abstract] [Full Text] [Related]
18. Soft Tissue Reconstruction After Sacral Neoplasm Resection: The University of California San Francisco Experience.
Falade IO; Knox JA; Piper ML; Hoffman WY; Hansen SL
Ann Plast Surg; 2024 May; 92(5S Suppl 3):S320-S326. PubMed ID: 38689413
[TBL] [Abstract] [Full Text] [Related]
19. PGRN is involved in macrophage M2 polarization regulation through TNFR2 in periodontitis.
Zhang L; Nie F; Zhao J; Li S; Liu W; Guo H; Yang P
J Transl Med; 2024 Apr; 22(1):407. PubMed ID: 38689292
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
[TBL] [Abstract] [Full Text] [Related]
[Next]
